Attachment A – Abstraction Form
Validation of Enhanced Algorithms to Identify Opioid Use and Co-Occurring Disorders in National Hospital Care Survey (NHCS)
Abstraction Form
OMB No. 0920-0212; Expiration date 03/31/2022
Notice of Estimated Burden – CDC estimates the average public reporting burden for this collection of information as 30 minutes per response, including the time for reviewing instructions, searching existing data/information sources, gathering and maintaining the data/information needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; ATTN: PRA (0920-0212).
Assurance of Confidentiality – We take your privacy very seriously. All information that relates to or describes identifiable characteristics of individuals, a practice, or an establishment will be used only for statistical purposes. NCHS staff, contractors, and agents will not disclose or release responses in identifiable form without the consent of the individual or establishment in accordance with section 308(d) of the Public Health Service Act (42USC 242m) and the Confidential Information Protection and Statistical Efficiency Act (Title III of the Foundations for Evidence-Based Policymaking Act of 2018 (Pub. L. No. 115-435, 132 Stat. 5529)). In accordance with CIPSEA, every NCHS employee, contractor, and agent has taken an oath and is subject to a jail term of up to five years, a fine of up to $250,000, or both if he or she willfully discloses ANY identifiable information about you.
|
Use the below prepopulated information to locate the full medical record for the selected encounter in the hospital’s EHR system. Verify that the correct medical record was selected before proceeding with abstraction. |
||
Hospital_ID |
XXXXXXXXXX
|
|
Encounter_ID |
XXXXXXXXXX
|
|
Medical Record Number (MRN) |
XXXXXXXXXXXXXXXXXXX
|
|
Setting |
|
|
Encounter Start Date |
DD MON YYYY
|
|
Encounter End Date |
DD MON YYYY
|
|
Patient Date of Birth |
DD MON YYYY
|
|
Patient Name |
LAST, FIRST MI
|
|
Patient Sex |
XXXXXXXXXXXX |
|
Patient Address |
XXXXXXXXXXXX |
Answer all the following questions using only information found in the medical record for the above referenced encounter. Exclude encounters that occurred before or after the referenced encounter. |
Question 1. |
Response |
Did the patient have at least one diagnosis related to past or present opioid use? (Select one)
|
Question 1a. |
Response |
|
Which diagnosis related to past or present opioid use did the patient have? (Select all that apply)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code.
|
Opioid related disorders
Poisoning by:
Adverse Effect of:
|
Underdosing of:
Miscellaneous Opioid Use:
|
Question 1b. |
Response |
|
Where did you find evidence of a diagnosis related to past or present opioid use? (Select all that apply)
|
|
|
Question 2. |
Response |
Did the patient have at least one written indication of past or present opioid use stated by the patient or provider other than the diagnosis(es) indicated in question 1? (Select one)
|
|
Question 2a. |
Response |
Describe the written indication of past or present opioid use, copy verbatim from chart when possible. (Enter up to three)
NOTE: Excludes diagnosis(es) indicated in Question 1. Include information regarding the intent of the opioid use if documented in the record (e.g., unintentional/accidental, suicide attempt & intentional self-harm, assault).
|
|
Question 2b. |
Response |
|
Where did you find evidence of the written indication of past or present opioid use? (Select all that apply) |
|
____________________ |
Question 3. |
Response |
Was any drug testing performed during the encounter? (Select one) |
|
Question 3a. |
Response |
Were any drug tests positive? (Select one) |
|
Question 3b. |
Response |
|
Which substance(s) had positive test results? (Select all that apply) |
|
__________________________
|
Question 3c. |
Response |
|
Where did you find evidence of drug testing? (Select all that apply) |
|
|
Question 4. |
Response |
Was at least one prescription opioid administered and/or prescribed to the patient during the encounter or listed on Past or Current Medication Lists? (Select one)
|
|
Question 4a. |
Response |
|
Which prescription opioid(s) was administered and/or prescribed to the patient? (Select all that apply) |
|
____________________ |
|
|
|
Response |
|
Question 4b. |
Opioid |
Prior to Encounter |
Given during Encounter |
Prescribed upon Discharge |
When was the prescription opioid(s) administered and/or prescribed to the patient? (Select all that apply)
NOTE: Opioids administered prior to encounter include those listed on Past and Current Medication Lists
|
Buprenorphine Codeine Fentanyl Hydrocodone Hydromorphone Methadone Morphine Oxycodone Oxymorphone Tramadol Other (please describe): ____________________ |
|
|
|
Question 4c. |
Response |
|
Where did you find evidence of opioid(s) administered and/or prescribed to the patient? (Select all that apply) |
|
|
Question 5. |
Response |
Was naloxone (Narcan) administered to the patient either during the encounter or shortly before arrival? (Select one) |
|
Question 5a. |
Response |
Who administered naloxone (Narcan)? (Select all that apply) |
|
Question 5b. |
Response |
How many doses of naloxone (Narcan) were administered? (Select one) |
|
Question 5c. |
Response |
Did naloxone (Narcan) administration result in a positive response (e.g., increased respiration and/or increased alertness)? (Select one) |
|
Question 5d. |
Response |
|
Where did you find evidence of naloxone (Narcan) administration? (Select all that apply) |
|
|
Question 6. |
Response |
Did the patient have at least one diagnosis related to a past or present substance use disorder? (Select one)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code.
|
|
Question 6a. |
Response |
Which diagnosis related to a past or present substance use disorder did the patient have? (Select all that apply)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code.
|
|
Question 6b. |
Response |
|
Where did you find evidence of a diagnosis related to past or present substance use disorder? (Select all that apply)
|
|
|
Question 7. |
Response |
Was there at least one written indication of past or present substance use disorder stated by the patient or provider other than the diagnosis(es) indicated in question 6? (Select one)
|
|
Question 7a. |
Response |
Describe the written indication of a past or present substance use disorder, copy verbatim from chart when possible. (Enter up to three)
NOTE: Excludes diagnosis(es) indicated in Question 6.
|
|
Question 7b. |
Response |
|
Where did you find evidence of a written indication of a past or present substance use disorder? (Select all that apply)
NOTE: Excludes diagnosis(es) indicated in Question 6.
|
|
|
Question 8. |
Response |
Did the patient have at least one diagnosis related to a past or present anxiety disorder? (Select one)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code. |
|
Question 8a. |
Response |
Which diagnosis related to a past or present anxiety disorder did the patient have? (Select all that apply)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code.
|
_____________________ |
Question 8b. |
Response |
|
Where did you find evidence of a diagnosis related to a past or present anxiety disorder? (Select all that apply)
|
|
|
Question 9. |
Response |
Was there at least one written indication of past or present anxiety disorder stated by the patient or provider other than the diagnosis indicated in question 8? (Select one)
|
|
Question 9a. |
Response |
Describe the written indication of a past or present anxiety disorder, copy verbatim from chart when possible. (Enter up to three)
NOTE: Excludes diagnosis(es) indicated in Question 8.
|
|
Question 9b. |
Response |
|
Where did you find evidence of a written indication of a past or present anxiety disorder? (Select all that apply)
NOTE: Excludes diagnosis(es) indicated in Question 8.
|
|
|
Question 10. |
Response |
Was there at least one diagnosis related to a past or present depressive disorder? (Select one)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code.
|
|
Question 10a. |
Response |
Which diagnosis related to a past or present depressive disorder did the patient have? (Select all that apply)
NOTE: Includes a diagnosis code or a diagnostic phrase, such as a label or description for a diagnosis code.
|
_____________________
|
Question 10b. |
Response |
|
Where did you find evidence of a diagnosis related to a past or present depressive disorder? (Select all that apply)
|
|
|
Question 11. |
Response |
Was there at least one written indication of past or present depressive disorder as stated by the patient or provider other than the diagnosis indicated in question 10? (Select one)
|
|
Question 11a. |
Response |
Describe the written indication of a past or present depressive disorder, copy verbatim from chart when possible. (Enter up to three)
NOTE: Excludes diagnosis(es) indicated in Question 10. For written indications of self-harm thoughts and behaviors, include whether they were related to a comorbidity of schizophrenia if documented in the record. |
|
Question 11b. |
Response |
|
Where did you find evidence of a written indication of a past or present depressive disorder? (Select all that apply)
NOTE: Excludes diagnosis(es) indicated in Question 10. |
|
|
Question 12. |
Response |
Was any treatment initiated for the patient’s substance use disorder (SUD), anxiety disorder and/or depressive disorder during this encounter? (Select one) |
|
Question 12a. |
Response |
|
What treatment was initiated during this encounter? (Select all that apply) |
|
________________________________ |
Question 12b. |
Response |
|
Where did you find evidence of treatment initiated during this encounter? (Select all that apply) |
|
|
Question 13. |
Response |
Abstractor Notes
Use this space to describe any issues with abstracting information for this encounter or any other pertinent information. |
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Williams, Bryan (CDC/DDPHSS/NCHS/DHCS) (CTR) |
File Modified | 0000-00-00 |
File Created | 2022-04-15 |